Final Rule Delayed Until at Least March 21, 2025
In a prepublication Federal Register notice (here), it was announced that the final rule “Nonprescription Drug Product With an Additional Condition for Nonprescription Use” has had its implementation date delayed until March 21, 2025. According to the notice, the “FDA published a final rule, titled ‘Nonprescription Drug Product With an Additional Condition for Nonprescription Use,’ in […]
